Related Experiment Video
Updated: Aug 7, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Defining standards of care for facilitated and direct percutaneous coronary intervention
1Division of Cardiology, Hĵpital la Pitié-Salpétrière, Institut de Cardialogie, Paris, France. gilles.montalescot@psi.ap-hop-paris.fr
Insights
Interventional cardiologists face choices in percutaneous coronary intervention (PCI). Optimizing therapies and patient transport are key to improving outcomes in this complex cardiac procedure.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Medicine
Background:
- Percutaneous coronary intervention (PCI) involves various procedural options and ongoing controversies.
- Key debates include routine stenting, use of embolic protection devices, and thrombectomy.
- Clinical trials have evaluated platelet glycoprotein IIb/IIIa inhibitors, with current focus on reperfusion and anticoagulation.
Purpose of the Study:
- To review current controversies and advancements in percutaneous coronary intervention (PCI).
- To discuss strategies for improving patient outcomes in PCI procedures.
- To highlight areas of ongoing research and clinical interest in interventional cardiology.
Main Methods:
- Review of existing clinical trials and established practices in interventional cardiology.
- Analysis of current controversies regarding PCI techniques and adjunctive therapies.
- Discussion of emerging strategies for optimizing reperfusion and anticoagulation.
Main Results:
- Controversies persist regarding routine stenting and adjunctive devices like filters and thrombectomy.
- Efficacy of platelet glycoprotein IIb/IIIa inhibitors has been a subject of clinical trials.
- Focus is shifting towards reducing reperfusion delays and enhancing anticoagulation protocols.
Conclusions:
- Optimizing existing and future therapies is crucial for improving patient outcomes in PCI.
- Advances in patient transport can contribute to better results.
- Addressing procedural delays and anticoagulation are critical areas for future research and practice improvement.
Abstract:
Interventional cardiologists have a variety of options when it comes to facilitated and direct percutaneous coronary intervention (PCI). Over the years, several controversies have surrounded the choices made before and during this process. Questions have been raised over the value of stenting all patients and the use of filters and thrombectomy devices. A number of important clinical trials have also investigated the efficacy of platelet glycoprotein IIb/IIIa inhibitors. Considerable interest is now taking place on how best to reduce reperfusion delays and to improve anticoagulation in the catheterization laboratory. Since direct PCI is often a slow process, better use of existing and future therapies, as well as advances in patient transport, are expected to improve patient outcomes.
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Cardiac Catheterization III: Left Heart Catheterization
Cardiac Catheterization IV: Nursing Management
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care

